Screener
Avalo Therapeutics AVTX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Avalo Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
FAQ
- What is Avalo Therapeutics's net margin?
- Avalo Therapeutics (AVTX) reported net margin of -7,965.8% in Q4 2024.
- How has Avalo Therapeutics's net margin changed year-over-year?
- Avalo Therapeutics's net margin decreased by 386.1% year-over-year, from -1,638.6% to -7,965.8%.
- What is the long-term trend for Avalo Therapeutics's net margin?
- Over 4 years (2020 to 2024), Avalo Therapeutics's net margin has grown at a 70.3% compound annual growth rate (CAGR), from -947.8% to -7,965.8%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Avalo Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude